Suchbegriffe: ALDOSTERONE RECEPTOR BLOCKADE, . Treffer: 2
Edelmann, F; Gelbrich, G; Duvinage, A; Stahrenberg, R; Behrens, A; Prettin, C; Kraigher-Krainer, E; Schmidt, AG; Düngen, HD; Kamke, W; Tschöpe, C; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Wachter, R; Pieske, B
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial.
Int J Cardiol. 2013; 169(6):408-417
Doi: 10.1016/j.ijcard.2013.10.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Edelmann, F; Schmidt, AG; Gelbrich, G; Binder, L; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Wachter, R; Pieske, B
Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF).
Eur J Heart Fail. 2010; 12(8):874-882
Doi: 10.1093/eurjhf/hfq087
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar